Skip to main content
Category

Resources

Cancer patient and woman in a warm embrace
Remote Symptom Alerts and Patient-Reported Outcomes (PROS) in Real-World Breast Cancer Practice: Innovative Data to Derive Symptom Burden and Quality of Life Resources

Remote Symptom Alerts and Patient-Reported Outcomes (PROS) in Real-World Breast Cancer Practice: Innovative Data to Derive Symptom Burden and Quality of Life

This paper demonstrates the value and application of Carevive PROs (patient-reported outcomes), combined with the alerts data, to characterize longitudinal symptom burden and quality of life of patients in the real-world oncology practice. Originally posted on MDPI. Abstract Treatment for breast cancer (BC) can lead to debilitating symptoms that can reduce outcomes and quality of life (QoL). Symptom surveillance using…
Carevive
August 20, 2024
Invaluable Oncology Insights PostersResources

Invaluable Oncology Insights

A Collection of Publications, Presentations, & Posters Carevive offers data across a broad set of cancer types, including solid and liquid tumors, leveraging our company’s knowledge and passion in conjunction with our innovative digital oncology platform we assist clients to gain data insights to their oncology value chain. A compilation of Carevive data and findings that was presented at major…
Carevive
July 19, 2024
ISPOR 2022
ISPOR 2022 Podium Presentation Resources

ISPOR 2022 Podium Presentation

Predictors of Symptom Worsening or Improvement using Remote Patient Reported Outcomes (PRO) Technology Carevive is using SMART DATA to identify symptom patterns and predictors leading to an automated alert of severe symptoms and symptom resolution after the alert. Using PROmpt®, a remote symptom reporting platform, patients receiving cancer treatment report symptom presence and severity weekly. Analyses of these data revealed…
Carevive
January 11, 2023
Poster: Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia by Cytogenetic Risk and Treatment Status
Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia by Cytogenetic Risk and Treatment Status PostersResources

Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia by Cytogenetic Risk and Treatment Status

This study demonstrates the feasibility of gathering PROs with real-world data among a cohort of patients with AML using a remote symptom monitoring platform, across baseline prognostic and therapeutic factors.
Carevive
December 12, 2022
Poster: Evaluation Of Treatment Choices At Baseline Among Breast Cancer Patients Based On The Frailty Status Of The Patients
Evaluation Of Treatment Choices At Baseline Among Breast Cancer Patients Based On The Frailty Status Of The Patients PostersResources

Evaluation Of Treatment Choices At Baseline Among Breast Cancer Patients Based On The Frailty Status Of The Patients

Previous studies have shown that frailty scores aid in better patient assessment and in advising treatment strategies for Acute Myeloid Leukemia (AML) (Jamy, et al., 2021), and Multiple Myeloma (Nathwani, et al., 2017, 2019). This study aims to evaluate the impact of frailty status on treatment choices among breast cancer patients.
Carevive
December 9, 2022
Poster: Patient-Reported Symptom Burden in Women Undergoing Treatment for Early-Stage and Metastatic Breast Cancer
Patient-Reported Symptom Burden in Women Undergoing Treatment for Early-Stage and Metastatic Breast Cancer PostersResources

Patient-Reported Symptom Burden in Women Undergoing Treatment for Early-Stage and Metastatic Breast Cancer

Women undergoing treatment for breast cancer experience both disease- and treatment-related symptoms. Remote symptom management (RSM) programs allow real-time symptom documentation, earlier intervention, and opportunities to improve quality of life and decrease symptom burden. Prior studies have focused on the supportive care needs of women with advanced breast cancer.
Carevive
December 9, 2022